Indicated for: nausea and vomiting
Route of administration: infusion
Substance: fosaprepitant (antiemetic)
ATC: A04AD12 (Alimentary tract and metabolism | Antiemetics and antinauseants | Other antiemetics)
Fosaprepitant is a medication used to prevent nausea and vomiting caused by cancer chemotherapy. It belongs to the class of neurokinin-1 (NK1) receptor antagonists and works by blocking signals in the brain that trigger the sensation of nausea.
Fosaprepitant is administered intravenously, usually before the start of chemotherapy, as part of a protocol combined with other antiemetic drugs. The dose is determined by your doctor based on the type and intensity of cancer treatment.
Side effects may include fatigue, headache, constipation, diarrhea, or reactions at the injection site. In rare cases, severe allergic reactions or changes in liver function may occur. Any unusual symptoms should be reported to the medical team immediately.
Fosaprepitant is an effective medication for preventing severe nausea associated with chemotherapy, helping to improve the quality of life for cancer patients. Follow your doctor's instructions and report any adverse reactions to ensure the safety of the treatment.